{"result": {"id": "d6325ded-6bfa-4730-b74f-03b5add37a09", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Gout and Hyperuricemia Community\",\n    \"summary\": \"The community revolves around gout and hyperuricemia, with key entities including gout, hyperuricemia, and related conditions such as kidney stones and arthritis. The relationships between these entities highlight the progression from hyperuricemia to gout and its complications, as well as the treatments available. This community is significant due to its impact on public health, with increasing prevalence rates in regions like the US and Europe.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the widespread prevalence of gout and hyperuricemia, their potential to lead to severe complications, and the significant public health burden they represent.\",\n    \"findings\": [\n        {\n            \"summary\": \"Hyperuricemia as the precursor to gout\",\n            \"explanation\": \"Hyperuricemia is directly linked to the development of gout, serving as its primary cause. This condition, characterized by elevated levels of uric acid in the blood, can progress to gout if not managed properly. The relationship between hyperuricemia and gout underscores the importance of early detection and management to prevent the onset of gout and its complications. [Data: Relationships (3862)]\"\n        },\n        {\n            \"summary\": \"Complications of gout\",\n            \"explanation\": \"Gout can lead to several complications, including the formation of kidney stones and chronic arthritis. These complications not only exacerbate the patient's condition but also complicate treatment strategies. The progression from acute gout attacks to chronic conditions highlights the need for effective long-term management strategies. [Data: Relationships (3879, 3951)]\"\n        },\n        {\n            \"summary\": \"Increasing prevalence of gout\",\n            \"explanation\": \"The prevalence of gout is increasing, particularly in the US, where rates have risen from 2.64% to 3.76% over two decades. This trend indicates a growing public health challenge and underscores the need for increased awareness and preventive measures. The data from Europe also shows significant prevalence rates, suggesting a global issue. [Data: Relationships (3863, 3864)]\"\n        },\n        {\n            \"summary\": \"Treatment options for gout and hyperuricemia\",\n            \"explanation\": \"Several treatment options are available for managing gout and hyperuricemia, including medications like allopurinol and febuxostat, which reduce uric acid production. Additionally, anti-inflammatory drugs and corticosteroids are used to manage acute gout attacks. The variety of treatments reflects the complexity of managing these conditions and the importance of personalized treatment plans. [Data: Entities (1420, 1421, 3944, 1754)]\"\n        },\n        {\n            \"summary\": \"Role of genetic factors in treatment response\",\n            \"explanation\": \"Genetic factors, such as the HLA-B*5801 gene, can influence the response to certain gout treatments, like allopurinol, increasing the risk of severe adverse reactions. This highlights the importance of genetic screening before initiating treatment to ensure patient safety and treatment efficacy. [Data: Relationships (3900)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560557, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 645, "prompt_tokens": 5964, "total_tokens": 6609, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1600}, "prompt_cache_hit_tokens": 1600, "prompt_cache_miss_tokens": 4364}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3884,痛风,\"痛风是一种由尿酸结晶沉积在关节所致的晶体相关性关节病，属于关节炎的一种。其发病机制与嘌呤代谢紊乱和/或尿酸排泄减少所导致的高尿酸血症直接相关。痛风的典型表现为关节红肿、疼痛，多发生于下肢关节，如第一跖趾关节、足背、踝关节等。急性发作期，多数患者会出现红细胞沉降率和C反应蛋白升高的现象。虽然症状可能自行缓解，但痛风易复发并逐渐加重。  \n\n此外，痛风患者常伴发肾脏病变及其他代谢综合征的表现，如高脂血症、高血压、糖尿病、冠心病等。治疗上需结合降尿酸治疗以控制高尿酸血症，并在急性期辅以抗炎镇痛治疗以缓解症状。\",28\n3885,高尿酸血症,高尿酸血症（Hyperuricemia）是一种以血液中尿酸水平升高为特征的代谢性疾病，主要由嘌呤代谢紊乱和/或尿酸排泄减少导致。该疾病与痛风有直接关联，可能进展为痛风，但在早期阶段常无明显症状。此外，高尿酸血症还被认为是一种独立的疾病，不仅促进缺血性卒中的发生，还与患者的不良预后相关。综合来看，高尿酸血症既是痛风的重要诱因，也是心脑血管疾病的潜在危险因素，其临床影响涵盖代谢异常和血管健康等多个方面。,7\n3900,痛风石,,3\n3931,尿酸性肾石症,\"尿酸性肾石症 (uric acid nephrolithiasis) is a kidney stone condition caused by the crystallization of uric acid in the kidneys. It is strongly associated with gout and elevated uric acid levels in the body. This condition is considered a clinical indication for urate-lowering therapy, which aims to reduce uric acid production or increase its excretion to prevent stone formation and related complications. The disorder highlights the interplay between metabolic abnormalities (such as hyperuricemia) and renal manifestations.\",2\n3886,欧洲,\"欧洲的痛风患病率为0.9%~2.5%。\"\"\",1\n3887,美国,\"美国的痛风患病率逐年增长，从1988—1994年的2.64%升至2007—2010年的3.76%。\"\"\",1\n3889,肾脏病变,\"痛风患者可伴发肾脏病变\"\"\",1\n3890,无症状高尿酸血症期,\"痛风自然病程的第一个阶段，表现为尿酸升高但无临床症状\"\"\",1\n3891,急性发作期,\"痛风自然病程的第二个阶段，表现为突发剧烈关节疼痛\"\"\",1\n3892,发作间歇期,\"痛风自然病程的第三个阶段，表现为症状缓解的间歇期\"\"\",1\n3893,慢性痛风石病变期,\"痛风自然病程的第四个阶段，表现为慢性关节损害和痛风石形成\"\"\",1\n3895,第一跖趾关节,\"第一跖趾关节是痛风最常见的发作部位，50%以上的首次发作发生于此。\"\"\",1\n3896,急性尿酸性肾病,\"急性尿酸性肾病是由于血和尿中尿酸浓度急剧上升，导致尿酸沉积并堵塞肾小管、集合管，引发急性少尿、无尿和急性肾衰竭。\"\"\",1\n3898,急性尿酸盐肾病,\"急性尿酸盐肾病由大量尿酸沉积堵塞肾小管引起，导致急性少尿、无尿和肾衰竭。\"\"\",1\n3899,尿酸性尿路结石,\"尿酸性尿路结石是痛风并发症，由尿酸盐沉积在泌尿系统形成。\"\"\",1\n3917,C反应蛋白,,1\n3913,红细胞沉降率,\"红细胞沉降率是一种炎症指标，痛风急性发作期多数患者会升高\"\"\",1\n3941,急性血尿酸显著升高,\"Acute significant hyperuricemia refers to dangerously high uric acid levels, often requiring urgent treatment\",1\n1420,别嘌醇,别嘌醇是一种抑制尿酸合成的药物，其作用机制是通过抑制黄嘌呤氧化酶的活性来减少尿酸的生成。该药物主要用于痛风患者的降尿酸治疗，帮助控制病情并缓解症状。,7\n1421,非布司他,非布司他是一种抑制尿酸合成的药物，通过抑制黄嘌呤氧化酶的活性来减少尿酸的生成。它主要用于痛风患者的降尿酸治疗。该药物的作用机制和临床应用在提供的描述中一致，强调了其作为尿酸合成抑制剂的核心功能及治疗痛风的主要用途。,6\n3944,非甾体抗炎药,非甾体抗炎药（NSAIDs）是一类药物，包含非特异性COX抑制剂和特异性COX-2抑制剂，主要用于痛风等疾病的疼痛和炎症管理。作为痛风急性发作的常用药物，非甾体抗炎药能有效缓解症状，但需注意其潜在的胃肠道和心血管风险。该类药物的作用机制涉及抑制环氧化酶（COX）活性，从而减少前列腺素的合成，达到抗炎、镇痛的效果。在使用时需权衡疗效与安全性，尤其针对存在基础疾病的患者。,5\n1754,糖皮质激素,\"糖皮质激素（Glucocorticoids）是一类类固醇激素，主要用于减轻炎症反应，并在多种疾病的治疗中发挥作用。它们可用于治疗急性痛风发作（尤其是伴随全身症状时），以及当秋水仙碱和非甾体抗炎药（NSAIDs）无效或存在禁忌时的替代方案。此外，低剂量的糖皮质激素还可用于治疗家族性高醛固酮血症Ⅰ型（Familial Hyperaldosteronism Type I）。  \n\n然而，糖皮质激素的使用可能伴随多种副作用，包括高血压和骨质疏松等，因此在临床应用中需谨慎评估风险与收益。其适应症涵盖炎症性疾病、内分泌紊乱及特定遗传性疾病，体现了广泛的治疗价值与潜在的用药风险。\",8\n3929,痛风患者,\"Individuals diagnosed with gout who may require urate-lowering therapy based on specific criteria\"\"\",5\n3912,痛风性关节炎,\"痛风性关节炎是一种疾病，超声检查对其诊断有意义\"\"\",7\n2447,中华内科杂志,\"The *中华内科杂志* (Chinese Journal of Internal Medicine) is a medical journal dedicated to publishing research, studies, and clinical guidelines in the field of internal medicine. It covers a broad range of topics within the discipline, including specialized areas such as gout management. The journal serves as a key resource for disseminating authoritative medical research and evidence-based practices in China. Its publications include original studies, reviews, and guideline recommendations aimed at advancing knowledge and improving patient care in internal medicine.\",4\n3923,美国风湿病学会,\"The **美国风湿病学会 (American College of Rheumatology, ACR)** is an organization dedicated to advancing the field of rheumatology. It provides clinical guidelines for the management of rheumatic diseases, including gout, with specific recommendations for urate-lowering therapy. Additionally, the ACR establishes classification criteria for various rheumatic conditions, such as gout, to standardize diagnosis and research. Through these efforts, the organization plays a key role in shaping best practices and improving patient care in rheumatology.\",7\n3943,秋水仙碱,秋水仙碱（Colchicine）是一种主要用于治疗和预防痛风发作的药物。在痛风急性发作时，建议在症状出现后12小时内开始使用，超过36小时后疗效可能下降。此外，它也可用于预防痛风发作，尤其是在初始降尿酸治疗阶段。使用时需根据患者的肾功能调整剂量，并注意可能出现的胃肠道不良反应及肝、肾功能损害等副作用。如果患者存在禁忌症，可考虑使用非甾体抗炎药（NSAIDs）或泼尼松（prednisone）作为替代治疗方案。,6\n3947,泼尼松,泼尼松（Prednisone）是一种糖皮质激素类药物，具有双重临床应用场景。在痛风治疗中，该药物既可作为急性发作期的治疗选择，推荐剂量为0.5mg·kg-1·d-1，标准疗程7-10天；同时也适用于长期预防性治疗，当其他药物疗效不足或存在禁忌时，可采用低剂量方案。这种差异化的应用体现了其剂量依赖性药理特性——较高剂量用于抑制急性炎症反应，而较低剂量则用于维持治疗。临床使用时需根据患者的具体病情阶段（急性发作期或慢性管理期）进行个体化给药方案制定。,3\n3911,HLA-B*5801基因,\"HLA-B*5801基因阳性与别嘌醇严重不良反应密切相关\"\"\",3\n3897,慢性痛风石关节炎,慢性痛风石关节炎是一种由关节内沉积大量单钠尿酸盐（MSU）晶体导致的疾病，主要表现为持续性关节肿痛、畸形和功能障碍，并可导致骨质破坏。超声检查对该疾病的诊断具有临床意义。该疾病属于慢性病程，通常伴随痛风石的形成，严重影响患者的生活质量和关节功能。,3\n3949,曲安奈德,曲安奈德（Triamcinolone Acetonide）是一种糖皮质激素类药物，主要用于关节腔内或肌肉注射以减轻炎症反应。其临床适应症包括治疗急性痛风发作，但使用前必须排除关节感染的可能性。该药物具有显著的抗炎作用，但同时也可能引发一系列不良反应，如血糖升高（高血糖）和骨质疏松等。作为糖皮质激素制剂，曲安奈德需在医生严格监督下使用，权衡其治疗效果与潜在风险。,2\n3924,欧洲抗风湿病联盟,The European Alliance of Associations for Rheumatology collaborates with the American College of Rheumatology to set classification criteria for diseases like gout,2\n3936,黄嘌呤氧化酶,,2\n3935,CARES研究,\"CARES研究评估了非布司他和别嘌醇在合并心血管疾病的痛风患者中的心血管安全性\"\"\",2\n3964,关节感染,\"A condition that must be ruled out before administering intra-articular glucocorticoid injections.\"\"\",1\n3894,嘌呤代谢紊乱,,1\n3888,尿酸排泄减少,\"尿酸排泄减少是导致高尿酸血症和痛风的主要原因之一\"\"\",1\n3906,缺血性卒中,\"缺血性卒中是一种神经系统疾病，与高尿酸血症相关\"\"\",1\n3907,神经退行性疾病,\"神经退行性疾病是一类疾病，血尿酸水平过低可能增加其发生风险\"\"\",1\n3914,双轨征,\"双轨征是尿酸沉积在关节内的特异性表现，诊断痛风性关节炎的敏感度为78%，特异度为97%\"\"\",1\n3915,暴风雪征,\"暴风雪征是关节积液内聚集的点状高回声，是痛风性关节炎的超声征象之一\"\"\",1\n3916,骨侵蚀,\"骨侵蚀是痛风性关节炎的超声征象之一，表现为骨质破坏\"\"\",1\n3930,无症状高尿酸血症患者,\"Individuals with elevated uric acid levels but no gout symptoms, for whom urate-lowering therapy is conditionally not recommended\"\"\",1\n3937,CARES,CARES is a study comparing the cardiovascular safety of febuxostat and allopurinol in gout patients with cardiovascular diseases,2\n3942,黄嘌呤氧化酶抑制剂,Xanthine oxidase inhibitors are a class of drugs including febuxostat and allopurinol used to treat gout,2\n3945,IL-1受体拮抗剂,\"IL-1受体拮抗剂可作为二线痛风急性发作期的治疗药物，适用于对一线药物不耐受或有禁忌的患者。\"\"\",2\n3925,痛风分类标准,The gout classification criteria is a diagnostic standard jointly developed by rheumatology organizations for identifying gout cases,3\n3950,环孢素A,,1\n3946,克拉霉素,\"克拉霉素是一种强效P-糖蛋白和CYP3A4抑制剂，与秋水仙碱存在药物相互作用，使用克拉霉素的患者禁用秋水仙碱。\"\"\",1\n3965,痛风急性发作,\"An inflammatory condition that can occur during initial uric acid-lowering therapy, often requiring preventive medication.\"\"\",3\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3862,痛风,高尿酸血症,\"痛风与高尿酸血症直接相关，高尿酸血症是痛风的主要病因。\n高尿酸血症是痛风的直接病因\",35\n3879,痛风,痛风石,长期未控制的痛风可导致痛风石形成,31\n3951,尿酸性肾石症,痛风,Gout can lead to uric acid nephrolithiasis as a complication,30\n3863,痛风,欧洲,欧洲的痛风患病率为0.9%~2.5%。,29\n3864,痛风,美国,美国的痛风患病率逐年增长，从1988—1994年的2.64%升至2007—2010年的3.76%。,29\n3866,痛风,肾脏病变,痛风患者可伴发肾脏病变,29\n3871,痛风,无症状高尿酸血症期,无症状高尿酸血症期是痛风病程的第一阶段,29\n3872,痛风,急性发作期,急性发作期是痛风病程的第二阶段,29\n3873,痛风,发作间歇期,发作间歇期是痛风病程的第三阶段,29\n3874,痛风,慢性痛风石病变期,慢性痛风石病变期是痛风病程的第四阶段,29\n3877,痛风,第一跖趾关节,痛风最常见的首次发作部位是第一跖趾关节,29\n3878,痛风,急性尿酸性肾病,痛风患者可能因尿酸浓度过高而引发急性尿酸性肾病,29\n3881,痛风,急性尿酸盐肾病,痛风患者尿酸水平过高可引发急性尿酸盐肾病,29\n3882,痛风,尿酸性尿路结石,痛风患者易并发尿酸性尿路结石,29\n3896,痛风,C反应蛋白,痛风急性发作期多数患者C反应蛋白升高,29\n3897,痛风,红细胞沉降率,痛风急性发作期多数患者红细胞沉降率升高,29\n3952,急性血尿酸显著升高,痛风,Acute significant hyperuricemia can occur in severe cases of gout,29\n1388,别嘌醇,非布司他,别嘌醇和非布司他均为抑制尿酸合成的药物，主要用于痛风患者的降尿酸治疗。两者通过减少尿酸生成来帮助控制痛风症状，属于同一类治疗药物，临床用途一致。,13\n3958,非甾体抗炎药,糖皮质激素,糖皮质激素在非甾体抗炎药无效或禁忌时使用，作为替代治疗。,13\n2000,糖皮质激素,家族性醛固酮增多症,Glucocorticoids are used to treat Familial Hyperaldosteronism Type I,12\n3926,痛风患者,痛风性关节炎,Gout patients experience recurrent gouty arthritis attacks as a defining symptom,12\n3921,中华内科杂志,美国风湿病学会,The American College of Rheumatology's guidelines are referenced in the Chinese Journal of Internal Medicine for gout management,11\n3953,秋水仙碱,非甾体抗炎药,\"秋水仙碱和非甾体抗炎药均为痛风治疗中的重要药物，具有两种主要临床应用。首先，它们都是痛风急性发作时的一线治疗药物，可根据患者的具体情况（如耐受性、并发症等）选择使用。其次，在患者接受降尿酸治疗（如别嘌醇或非布司他）的初期阶段，两者均可用于预防痛风发作。这一双重作用机制使其在痛风管理的不同阶段（急性期与长期降尿酸治疗过渡期）均具有重要地位。  \n\n（注：通过合并两处描述，明确了药物在\"\"急性发作治疗\"\"和\"\"降尿酸治疗初期预防\"\"的双重角色，未发现矛盾信息，临床定位互补。）\",11\n3961,糖皮质激素,泼尼松,泼尼松是糖皮质激素的一种具体药物，用于急性痛风发作的治疗。,11\n3900,HLA-B*5801基因,别嘌醇,HLA-B*5801基因阳性与别嘌醇严重不良反应密切相关,10\n3901,痛风性关节炎,慢性痛风石关节炎,两者都是痛风相关的关节炎，超声检查对其诊断有意义,10\n3963,糖皮质激素,曲安奈德,曲安奈德是糖皮质激素的一种具体药物，可用于关节腔内注射治疗痛风。,10\n3913,美国风湿病学会,欧洲抗风湿病联盟,The American College of Rheumatology and the European Alliance of Associations for Rheumatology jointly developed the gout classification criteria,9\n3934,别嘌醇,黄嘌呤氧化酶,别嘌醇通过抑制黄嘌呤氧化酶活性来减少尿酸合成,9\n3936,别嘌醇,CARES研究,CARES研究评估了别嘌醇在心血管疾病患者中的安全性,9\n3974,糖皮质激素,关节感染,Joint infections must be excluded before using glucocorticoid injections.,9\n3875,高尿酸血症,嘌呤代谢紊乱,嘌呤代谢紊乱直接导致高尿酸血症,8\n3876,高尿酸血症,尿酸排泄减少,尿酸排泄减少直接导致高尿酸血症,8\n3894,高尿酸血症,缺血性卒中,高尿酸血症促进了缺血性卒中的发生,8\n3895,高尿酸血症,神经退行性疾病,血尿酸水平过低可能增加神经退行性疾病发生的风险,8\n3902,痛风性关节炎,双轨征,双轨征是诊断痛风性关节炎的特异性表现,8\n3903,痛风性关节炎,暴风雪征,暴风雪征是痛风性关节炎的超声征象之一,8\n3905,痛风性关节炎,骨侵蚀,骨侵蚀是痛风性关节炎的晚期表现,8\n3923,美国风湿病学会,无症状高尿酸血症患者,The American College of Rheumatology conditionally opposes urate-lowering therapy for asymptomatic hyperuricemia patients,8\n3937,非布司他,黄嘌呤氧化酶,非布司他通过抑制黄嘌呤氧化酶活性来减少尿酸合成,8\n3940,CARES,非布司他,Febuxostat was studied in the CARES research for its cardiovascular safety,8\n3944,非布司他,黄嘌呤氧化酶抑制剂,Febuxostat belongs to the class of xanthine oxidase inhibitors,8\n3955,秋水仙碱,IL-1受体拮抗剂,IL-1受体拮抗剂作为二线药物，适用于对秋水仙碱不耐受或有禁忌的患者。,8\n3916,痛风分类标准,中华内科杂志,The Chinese Journal of Internal Medicine published the gout classification criteria in 2023,7\n3956,秋水仙碱,环孢素A,环孢素A会抑制秋水仙碱的代谢，增加其毒性，因此使用环孢素A的患者禁用秋水仙碱。,7\n3957,秋水仙碱,克拉霉素,克拉霉素会抑制秋水仙碱的代谢，增加其毒性，因此使用克拉霉素的患者禁用秋水仙碱。,7\n3976,痛风急性发作,中华内科杂志,The journal published treatment guidelines for gout acute发作 prevention.,7\n3883,慢性痛风石关节炎,痛风石,痛风石与慢性痛风石关节炎常同时存在,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_6748a5ea9b7fc6a850cd46336402cbacfaac4dfd444343662514dc707b55a3aa_v2"}